US Peripheral Neuropathy Treatment Market is estimated to grow at a CAGR of 4.6% during the forecast period. Significant rise in the prevalence of diabetes is the major factor accelerating the demand for peripheral neuropathy treatment in the US. As per the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, […]
